President Cyril Ramaphosa has slammed travel bans imposed on South Africa as countries around the world continue to react with apprehension to the emergence and reporting of the Covid-19 Omicron variant.
Legal experts say vaccine mandates are likely defensible in court; scientists are getting a better picture of the Omicron variant, despite it still being early days; latest fuel hikes will put consumers under extreme pressure; and Mbalula sets yet anot...
Civil society group Afriforum says it will oppose the introduction of Covid-19 vaccination mandates in South Africa, citing Constitutional issues.
The Congress of South African Trade Unions (Cosatu) has thrown its support behind the government's plan to encourage Covid-19 vaccinations over damaging lockdown restrictions.
Scientists call for vaccine mandates in South Africa; global travel bans leave South Africans stranded; international investors want to pull out of SA because of Prasa's mess; and the ANC tries to shake some of the blame for its election…
President Cyril Ramaphosa says that South Africa will keep its lockdown restrictions unchanged at level 1, but will look to offer booster shots to the elderly, and strengthen rules around vaccinations.
President Cyril Ramaphosa will address the nation at 20h00 on Sunday (28 November) on developments in the country’s response to the Covid-19 pandemic.
Health minister Joe Phaahla says the government has not made any decisions regarding tighter lockdown restrictions following the emergence of the Omicron Covid variant this week.
Business and civil society groups have warned that president Cyril Ramaphosa and his government will face significant backlash from the public if he reintroduces stricter lockdown restrictions this week in response to a new Omicron Covid-19 variant.
Business and civil society groups have warned that president Cyril Ramaphosa and his government will face significant backlash from the public if he reintroduces stricter lockdown restrictions this week in response to a new Omicron Covid-19 variant.